182 related articles for article (PubMed ID: 8277248)
1. Structure and antigenicity of lipoarabinomannan from Mycobacterium bovis BCG.
Prinzis S; Chatterjee D; Brennan PJ
J Gen Microbiol; 1993 Nov; 139(11):2649-58. PubMed ID: 8277248
[TBL] [Abstract][Full Text] [Related]
2. Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium.
Khoo KH; Dell A; Morris HR; Brennan PJ; Chatterjee D
J Biol Chem; 1995 May; 270(21):12380-9. PubMed ID: 7759478
[TBL] [Abstract][Full Text] [Related]
3. Structural features of lipoarabinomannan from Mycobacterium bovis BCG. Determination of molecular mass by laser desorption mass spectrometry.
Venisse A; Berjeaud JM; Chaurand P; Gilleron M; Puzo G
J Biol Chem; 1993 Jun; 268(17):12401-11. PubMed ID: 8509380
[TBL] [Abstract][Full Text] [Related]
4. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages.
Schlesinger LS; Hull SR; Kaufman TM
J Immunol; 1994 Apr; 152(8):4070-9. PubMed ID: 8144972
[TBL] [Abstract][Full Text] [Related]
5. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages.
Schlesinger LS; Kaufman TM; Iyer S; Hull SR; Marchiando LK
J Immunol; 1996 Nov; 157(10):4568-75. PubMed ID: 8906835
[TBL] [Abstract][Full Text] [Related]
6. Lipoarabinomannan mannose caps do not affect mycobacterial virulence or the induction of protective immunity in experimental animal models of infection and have minimal impact on in vitro inflammatory responses.
Afonso-Barroso A; Clark SO; Williams A; Rosa GT; Nóbrega C; Silva-Gomes S; Vale-Costa S; Ummels R; Stoker N; Movahedzadeh F; van der Ley P; Sloots A; Cot M; Appelmelk BJ; Puzo G; Nigou J; Geurtsen J; Appelberg R
Cell Microbiol; 2013 Apr; 15(4):660-74. PubMed ID: 23121245
[TBL] [Abstract][Full Text] [Related]
7. Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains.
Chatterjee D; Lowell K; Rivoire B; McNeil MR; Brennan PJ
J Biol Chem; 1992 Mar; 267(9):6234-9. PubMed ID: 1556132
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of the mannan region of lipoarabinomannan from Mycobacterium bovis BCG. Heterogeneity in phosphorylation state.
Venisse A; Rivière M; Vercauteren J; Puzo G
J Biol Chem; 1995 Jun; 270(25):15012-21. PubMed ID: 7797482
[TBL] [Abstract][Full Text] [Related]
9. Structural definition of the non-reducing termini of mannose-capped LAM from Mycobacterium tuberculosis through selective enzymatic degradation and fast atom bombardment-mass spectrometry.
Chatterjee D; Khoo KH; McNeil MR; Dell A; Morris HR; Brennan PJ
Glycobiology; 1993 Oct; 3(5):497-506. PubMed ID: 8286863
[TBL] [Abstract][Full Text] [Related]
10. Genetic basis for the synthesis of the immunomodulatory mannose caps of lipoarabinomannan in Mycobacterium tuberculosis.
Dinadayala P; Kaur D; Berg S; Amin AG; Vissa VD; Chatterjee D; Brennan PJ; Crick DC
J Biol Chem; 2006 Jul; 281(29):20027-35. PubMed ID: 16704981
[TBL] [Abstract][Full Text] [Related]
11. New structural insights into the molecular deciphering of mycobacterial lipoglycan binding to C-type lectins: lipoarabinomannan glycoform characterization and quantification by capillary electrophoresis at the subnanomole level.
Nigou J; Vercellone A; Puzo G
J Mol Biol; 2000 Jun; 299(5):1353-62. PubMed ID: 10873458
[TBL] [Abstract][Full Text] [Related]
12. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan.
Maeda N; Nigou J; Herrmann JL; Jackson M; Amara A; Lagrange PH; Puzo G; Gicquel B; Neyrolles O
J Biol Chem; 2003 Feb; 278(8):5513-6. PubMed ID: 12496255
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium marinum MMAR_2380, a predicted transmembrane acyltransferase, is essential for the presence of the mannose cap on lipoarabinomannan.
Driessen NN; Stoop EJM; Ummels R; Gurcha SS; Mishra AK; Larrouy-Maumus G; Nigou J; Gilleron M; Puzo G; Maaskant JJ; Sparrius M; Besra GS; Bitter W; Vandenbroucke-Grauls CMJE; Appelmelk BJ
Microbiology (Reading); 2010 Nov; 156(Pt 11):3492-3502. PubMed ID: 20688818
[TBL] [Abstract][Full Text] [Related]
14. Lipoarabinomannans: from structure to biosynthesis.
Nigou J; Gilleron M; Puzo G
Biochimie; 2003; 85(1-2):153-66. PubMed ID: 12765785
[TBL] [Abstract][Full Text] [Related]
15. Truncated structural variants of lipoarabinomannan in Mycobacterium leprae and an ethambutol-resistant strain of Mycobacterium tuberculosis.
Torrelles JB; Khoo KH; Sieling PA; Modlin RL; Zhang N; Marques AM; Treumann A; Rithner CD; Brennan PJ; Chatterjee D
J Biol Chem; 2004 Sep; 279(39):41227-39. PubMed ID: 15263002
[TBL] [Abstract][Full Text] [Related]
16. Lipoarabinomannan of Mycobacterium: mannose capping by a multifunctional terminal mannosyltransferase.
Kaur D; Obregón-Henao A; Pham H; Chatterjee D; Brennan PJ; Jackson M
Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17973-7. PubMed ID: 19004785
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans.
Kaur D; Lowary TL; Vissa VD; Crick DC; Brennan PJ
Microbiology (Reading); 2002 Oct; 148(Pt 10):3049-3057. PubMed ID: 12368438
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterial mannose-capped lipoarabinomannan: a modulator bridging innate and adaptive immunity.
Zhou KL; Li X; Zhang XL; Pan Q
Emerg Microbes Infect; 2019; 8(1):1168-1177. PubMed ID: 31379262
[TBL] [Abstract][Full Text] [Related]
19. A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production.
Garton NJ; Gilleron M; Brando T; Dan HH; Giguère S; Puzo G; Prescott JF; Sutcliffe IC
J Biol Chem; 2002 Aug; 277(35):31722-33. PubMed ID: 12072437
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha.
Roach TI; Barton CH; Chatterjee D; Blackwell JM
J Immunol; 1993 Mar; 150(5):1886-96. PubMed ID: 8436823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
